| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIOLINERX LTD | 250,000 | 405,000 | 0.20% | ||
| 2 | CARA THERAPEUTICS INC | 80,000 | 798,000 | 0.40% | ||
| 3 | NEUROCRINE BIOSCIE COM USD0.001 | 45,000 | 1,005,000 | 0.51% | ||
| 4 | EVOKE PHARMA INC | 240,000 | 1,416,000 | 0.72% | ||
| 5 | TENAX THERAPEUTICS INC | 440,000 | 1,690,000 | 0.85% | ||
| 6 | CELGENE CORP | 575,000 | 1,811,000 | 0.92% | ||
| 7 | ACCELERATE DIAGNOSTICS INC | 100,000 | 1,919,000 | 0.97% | ||
| 8 | ALNYLAM PHARMACEUTICALS INC | 29,100 | 2,823,000 | 1.43% | ||
| 9 | HORIZON PHARMA PLC | 220,000 | 2,836,000 | 1.43% | ||
| 10 | CATALYST PHARMACEUTICALS INC | 975,000 | 2,896,000 | 1.46% | ||
| 11 | SUPERNUS PHARMACEUTICALS INC | 350,000 | 2,905,000 | 1.47% | ||
| 12 | TRILLIUM THERAPEUTICS INC | 333,333 | 3,000,000 | 1.52% | ||
| 13 | PARATEK PHARMACEUTICALS INC | 80,000 | 3,084,000 | 1.56% | ||
| 14 | FLUIDIGM CORP DEL COM | 95,000 | 3,204,000 | 1.62% | ||
| 15 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 205,000 | 3,512,000 | 1.77% | ||
| 16 | CARDIOVASCULAR SYS INC DEL COM | 125,000 | 3,760,000 | 1.90% | ||
| 17 | ONCOTHYREON INC | 2,000,000 | 3,800,000 | 1.92% | ||
| 18 | IMPRIMIS PHARMACEUTICALS INC | 560,000 | 4,200,000 | 2.12% | ||
| 19 | MEDGENICS INC | 850,000 | 4,301,000 | 2.17% | ||
| 20 | Codexis Inc Com | 1,724,000 | 4,344,000 | 2.20% | ||
| 21 | KITE PHARMA INCORPORATED | 76,000 | 4,383,000 | 2.21% | ||
| 22 | OPHTHOTECH CORP | 100,000 | 4,487,000 | 2.27% | ||
| 23 | GENMARK DIAGNOSTICS INC. | 335,000 | 4,559,000 | 2.30% | ||
| 24 | ULTRAGENYX PHARMACEUTICAL INC COM | 106,200 | 4,660,000 | 2.35% | ||
| 25 | INSYS THERAPEUTICS INC NEW COM NEW | 122,500 | 5,165,000 | 2.61% | ||
| 26 | FIBROGEN INC | 191,338 | 5,231,000 | 2.64% | ||
| 27 | VERSARTIS INC | 235,000 | 5,276,000 | 2.67% | ||
| 28 | GERON CORP | 1,825,000 | 5,931,000 | 3.00% | ||
| 29 | TETRAPHASE PHARMACEUTICALS INC COM | 189,700 | 7,533,000 | 3.81% | ||
| 30 | CLOVIS ONCOLOGY INC | 140,000 | 7,840,000 | 3.96% | ||
| 31 | PHARMACYCLICS INC | 85,000 | 10,392,000 | 5.25% | ||
| 32 | ARIAD PHARMACEUTICALS ORD (NMS) | 1,525,000 | 10,477,000 | 5.29% | ||
| 33 | RETROPHIN INC | 920,000 | 11,261,000 | 5.69% | ||
| 34 | CEMPRA INC | 504,800 | 11,868,000 | 6.00% | ||
| 35 | AGIOS PHARMACEUTICALS INC | 113,500 | 12,717,000 | 6.43% | ||
| 36 | CHIMERIX INC | 805,000 | 32,409,000 | 16.38% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001546927-15-000070, filed 2015.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
